Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab

Clin Adv Hematol Oncol. 2006 Jun;4(6):439-41.

Authors

Aileen Go¹, Parameswaran Venugopal, Jerome Loew, Dragan Djordjevic

Affiliation

¹ Rush University Medical Center Chicago, Ill, USA. aileen_go@rush.edu

PMID: 16981666

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Brain Neoplasms / diagnosis
Brain Neoplasms / drug therapy*
Brain Neoplasms / pathology
Central Nervous System / pathology*
Dose-Response Relationship, Drug
Female
Humans
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Lymphoma, Large B-Cell, Diffuse / pathology
Recurrence
Remission Induction
Rituximab
Sensitivity and Specificity
Tomography, Emission-Computed / methods
Treatment Outcome
Vascular Neoplasms / diagnosis
Vascular Neoplasms / drug therapy*
Vascular Neoplasms / pathology

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Rituximab